MMJ's position is further fortified by its FDA Orphan Drug Designations for the treatment of Huntington's Disease. These designations are awarded to drugs intended for the safe and effective treatment ...

LIVE FOREVER HEALTH™ UNVEILS FULL-STACK HORMONE & TELEMEDICINE FRANCHISE MODEL, PIONEERING LONGEVITY CARE IN ALL 50 STATESThe Specialized Health Leader Offers a Turnkey System for Entrepreneurs to ...

From combination surgeries to advanced skin therapies, The Naderi Center outlines how patients nationwide are prioritizing facial harmony as the foundation of modern aesthetics. WASHINGTON, D.C. / ...

Potential Schedule III Status Could Improve Legal Clarity for Patients Traveling from Colombia to the United States with Prescribed Medical Cannabis CALI, COLOMBIA / ACCESS Newswire / December 22, ...

Advancing Open Innovation in Drug Discovery and Facilitating Reliable Market IntroductionTOKYO--(BUSINESS WIRE)--Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from ...

This acquisition establishes Niagen Bioscience as the sole owner of the most comprehensive and defensible intellectual property portfolio in the NAD+ industryLOS ANGELES--(BUSINESS WIRE)--$NAGE ...

The new website showcases the company's commitment to innovation and its mission to better serve healthcare providers in the gastrointestinal community. MILWAUKEE, WI / ACCESS Newswire / December 22, ...

Weekly Oral Helicase-Primase Inhibitor Programs' Early Data Potentially Supportive of First New Treatment for Recurrent ...

Shionogi to purchase the rights and assets of the global RADICAVA business establishing a strong commercial platform in rare disease to support future launchesAs part of the transaction, a new ...

Shape Memory Medical Inc., innovator of the proprietary shape memory polymer technology for endovascular applications, announced that its IMPEDE® Embolization Plug product family has received ...

Predicting how a person’s heart will respond to a new medicine remains one of the most persistent blind spots in drug ...

TORONTO, ONTARIO / ACCESS Newswire / December 22, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"),understands that Quantum BioPharma shareholder Paul Durkacz has ...